Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q4 2023 Earnings

19MarConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.91

-0.85

-0.79

-0.73

Details

Expected EPS

-0.83

Actual EPS

-0.84

Surprise EPS

-0.01

Surprise Percent

+1.2%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.84 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.